• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似乳糜泻儿童中tTG-IgA滴度与十二指肠活检结果的相关性评估

Evaluation of the Correlation Between tTG-IgA Titer and Duodenal Biopsy Findings in Children With Suspected Celiac Disease.

作者信息

Aldaghi Mitra-Azra, Dehghani Seyed-Mohsen, Haghighat Mahmood

机构信息

Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, IR Iran.

出版信息

Iran J Pediatr. 2016 Feb;26(1):e3615. doi: 10.5812/ijp.3615. Epub 2016 Jan 30.

DOI:10.5812/ijp.3615
PMID:26848375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4733291/
Abstract

BACKGROUND

Celiac disease is an immune-mediated inflammation of the small intestine caused by sensitivity to dietary gluten in genetically sensitive individuals.

OBJECTIVES

In this study, we aimed to evaluate the predictive value of tissue transglutaminase (tTG) antibodies for the diagnosis of celiac disease in a pediatric population in order to determine if duodenal biopsy can be avoided.

PATIENTS AND METHODS

The subjects were selected among individuals with probable celiac disease, referring to a gastrointestinal clinic. After physical examinations and performing tissue transglutaminase-immunoglobulin A (tTG-IgA) tests, upper endoscopy was performed if serological titer was higher than 18 IU/mL. Therapy started according to pathologic results.

RESULTS

The sample size was calculated to be 121 subjects (69 female and 52 male subjects); the average age of subjects was 8.4 years. A significant association was found between serological titer and pathologic results; in other words, subjects with high serological titer had more positive pathologic results for celiac disease, compared to others (P < 0.001). Maximum sensitivity (65%) and specificity (65.4%) were achieved at a serological titer of 81.95 IU/ml; the calculated accuracy was lower in comparison with other studies. As the results indicated, lower antibody titer was observed in patients with failure to gain weight and higher antibody titer was reported in diabetic patients.

CONCLUSIONS

As the results indicated, a single serological test (tTg-IgA test) was not sufficient for avoiding intestinal biopsy.

摘要

背景

乳糜泻是一种由遗传敏感个体对膳食麸质敏感引起的小肠免疫介导性炎症。

目的

在本研究中,我们旨在评估组织转谷氨酰胺酶(tTG)抗体对儿科人群乳糜泻诊断的预测价值,以确定是否可以避免十二指肠活检。

患者与方法

研究对象从疑似乳糜泻的个体中选取,这些个体前往胃肠病诊所就诊。在进行体格检查和组织转谷氨酰胺酶 - 免疫球蛋白A(tTG - IgA)检测后,如果血清学滴度高于18 IU/mL,则进行上消化道内镜检查。根据病理结果开始治疗。

结果

计算得出样本量为121名受试者(69名女性和52名男性受试者);受试者的平均年龄为8.4岁。发现血清学滴度与病理结果之间存在显著关联;也就是说,与其他受试者相比,血清学滴度高的受试者乳糜泻病理结果阳性更多(P < 0.001)。血清学滴度为81.95 IU/ml时达到最大敏感性(65%)和特异性(65.4%);与其他研究相比,计算得出的准确性较低。结果表明,体重未增加的患者抗体滴度较低,糖尿病患者抗体滴度较高。

结论

结果表明,单一血清学检测(tTg - IgA检测)不足以避免肠道活检。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/4733291/bf8bb33c195e/ijp-26-3615-i002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/4733291/520921c36dbd/ijp-26-3615-i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/4733291/bf8bb33c195e/ijp-26-3615-i002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/4733291/520921c36dbd/ijp-26-3615-i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c843/4733291/bf8bb33c195e/ijp-26-3615-i002.jpg

相似文献

1
Evaluation of the Correlation Between tTG-IgA Titer and Duodenal Biopsy Findings in Children With Suspected Celiac Disease.疑似乳糜泻儿童中tTG-IgA滴度与十二指肠活检结果的相关性评估
Iran J Pediatr. 2016 Feb;26(1):e3615. doi: 10.5812/ijp.3615. Epub 2016 Jan 30.
2
Correlation of TTG IgA Level with Small Intestinal Histopathological Changes for Celiac Disease among Adult Saudi Patients.沙特成年患者中乳糜泻患者TTG IgA水平与小肠组织病理学变化的相关性
J Transl Int Med. 2020 May 9;8(1):48-53. doi: 10.2478/jtim-2020-0008. eCollection 2020 Mar.
3
Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.基于抗体的策略在儿科乳糜泻诊断中的验证:无需活检。
Gastroenterology. 2017 Aug;153(2):410-419.e17. doi: 10.1053/j.gastro.2017.04.023. Epub 2017 Apr 28.
4
IgA anti-actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage.抗肌动蛋白 IgA 抗体在小儿乳糜泻中的研究:免疫荧光法与 ELISA 法在预测严重肠道损伤中的比较。
Ital J Pediatr. 2010 Mar 18;36:25. doi: 10.1186/1824-7288-36-25.
5
Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients.组织转谷氨酰胺酶酶联免疫吸附测定作为儿科患者乳糜泻的筛查试验。
Pediatrics. 2001 Jan;107(1):E8. doi: 10.1542/peds.107.1.e8.
6
Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease.乳糜泻患儿组织转谷氨酰胺酶抗体滴度与十二指肠组织学改变的相关性
Gastroenterol Res Pract. 2016;2016:6718590. doi: 10.1155/2016/6718590. Epub 2016 Oct 27.
7
[Predictive value of serological tests in the diagnosis of celiac disease].[血清学检测在乳糜泻诊断中的预测价值]
Ann Ital Med Int. 2002 Apr-Jun;17(2):102-7.
8
Do Serological Tests Eliminate the Need for Endoscopic Biopsy for the Diagnosis of Symptomatic Patients with Celiac Disease? A Retrospective Study with Review of Literature.血清学检测能否取代内镜活检用于诊断有症状的乳糜泻患者?一项回顾性研究及文献综述
Middle East J Dig Dis. 2023 Oct;15(4):263-269. doi: 10.34172/mejdd.2023.356. Epub 2023 Oct 30.
9
Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.血清转谷氨酰胺酶和肌内膜抗体检测无法检出大多数采用无麸质饮食的乳糜泻和持续性绒毛萎缩患者:一项荟萃分析。
Gastroenterology. 2017 Sep;153(3):689-701.e1. doi: 10.1053/j.gastro.2017.05.015. Epub 2017 May 22.
10
Tissue Transglutaminase Antibody and Its Association with Duodenal Biopsy in Diagnosis of Pediatric Celiac Disease.组织转谷氨酰胺酶抗体及其在小儿乳糜泻诊断中与十二指肠活检的关联。
Pediatr Gastroenterol Hepatol Nutr. 2019 Jul;22(4):350-357. doi: 10.5223/pghn.2019.22.4.350. Epub 2019 Jun 20.

引用本文的文献

1
Frequency of overweight/obesity among a group of children with celiac disease in Iran.伊朗一组患有乳糜泻的儿童中超重/肥胖的发生率。
Prz Gastroenterol. 2018;13(2):127-131. doi: 10.5114/pg.2018.73347. Epub 2018 Feb 7.

本文引用的文献

1
Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests.诊断乳糜泻并非必须进行肠活检:联合抗体检测的回顾性分析。
BMC Gastroenterol. 2013 Jan 23;13:19. doi: 10.1186/1471-230X-13-19.
2
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.欧洲儿科胃肠病学、肝病学和营养学学会关于乳糜泻诊断的指南。
J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60. doi: 10.1097/MPG.0b013e31821a23d0.
3
The role of duodenal bulb biopsy in the diagnosis of celiac disease in children.
十二指肠球部活检在儿童乳糜泻诊断中的作用。
J Clin Gastroenterol. 2011 Jan;45(1):26-9. doi: 10.1097/MCG.0b013e3181e04d26.
4
Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable?不同术前概率患者的乳糜泻血清学检查:是否可以避免活检?
World J Gastroenterol. 2010 Jul 7;16(25):3144-52. doi: 10.3748/wjg.v16.i25.3144.
5
Very high rate of misdiagnosis of celiac disease in clinical practice.临床实践中乳糜泻的误诊率极高。
Acta Gastroenterol Latinoam. 2009 Dec;39(4):250-3.
6
Duodenal biopsy may be avoided when high transglutaminase antibody titers are present.如果转谷氨酰胺酶抗体滴度高,则可避免进行十二指肠活组织检查。
World J Gastroenterol. 2009 Oct 14;15(38):4775-80. doi: 10.3748/wjg.15.4775.
7
Autoimmune liver disease associated with celiac disease in childhood: a multicenter study.儿童期自身免疫性肝病与乳糜泻的相关性:一项多中心研究。
Clin Gastroenterol Hepatol. 2008 Jul;6(7):803-6. doi: 10.1016/j.cgh.2007.12.002. Epub 2008 Feb 7.
8
Celiac disease in the developing countries: a new and challenging public health problem.发展中国家的乳糜泻:一个新的且具有挑战性的公共卫生问题。
World J Gastroenterol. 2007 Apr 21;13(15):2153-9. doi: 10.3748/wjg.v13.i15.2153.
9
Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests).系统评价:血清学检测在排除或诊断乳糜泻中的应用(肌内膜抗体与组织转谷氨酰胺酶抗体检测的比较)
Aliment Pharmacol Ther. 2006 Jul 1;24(1):47-54. doi: 10.1111/j.1365-2036.2006.02967.x.
10
Diagnosis of coeliac disease.乳糜泻的诊断
Best Pract Res Clin Gastroenterol. 2005 Jun;19(3):389-400. doi: 10.1016/j.bpg.2005.02.006.